Roche strives to address unmet medical needs through excellence in Science. Spreading breakthroughs in science and technology allows HCP to find out precisely what is malfunctioning in the body and contributes to generate new questions to be answered. We are committed to support Medical Education as it is the driving force of excellence in Science. We are Roche.

Seagen is committed to supporting innovative, high quality medical education for healthcare professionals that addresses unmet medical needs, fosters clinical excellence and improves health outcomes.

At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.

Through bold and transformative science, we’re driving innovation that has the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.

Menarini Stemline es una compañía farmacéutica que forma parte del Grupo Menarini, con foco exclusivo en la investigación y el desarrollo de terapias innovadoras en oncología y onco-hematología. Entre nuestros objetivos, se encuentra el trabajar con todas las instituciones sanitarias, sociedades científicas, entidades académicas y asociaciones de pacientes, con el fin de mejorar la vida de las personas con cáncer en España. Para ello, es fundamental nuestro compromiso con la formación continuada y la actualización de los profesionales sanitarios, clave para la excelencia en la atención a los pacientes que ofrece el Sistema Nacional de Salud. Para ello, damos apoyo a algunas iniciativas de educación médica punteras desarrolladas por las organizaciones de referencia en oncología y onco-hematología de nuestro país.

At Lilly, our commitment to medical education and training of oncology professionals is critical to advancing cancer treatment. Through training programs and collaborations with scientific groups like SOLTI, we seek to provide access to cutting-edge knowledge and tools that help healthcare professionals improve the lives of their patients. Together, we continue to drive innovation and excellence in cancer care.